Table 2.
Treatment after EP
| Regimen | N |
|---|---|
| No additional anti-tumor treatment/supportive care alone | 9 |
| BEV alone | 8 |
| BEV + re-irradiation, followed with BEV + BCNU | 1 |
| BEV + BCNU | 1 |
BEV Bevacizumab
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.